poisar

Stocks · News reference

Dogwood Therapeutics Announces Virtual KOL Event On September 1 To Discuss Halneuron In Chemotherapy Induced Neuropathic Pain; Says Positive Interim Phase 2b Results To Be Reviewed

Benzinga Newsdesk
More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

DWTX
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Benzinga Newsdesk

    Dogwood Therapeutics Q2 EPS $(0.34) Misses $(0.14) Estimate

    Dogwood Therapeutics (NASDAQ:DWTX) reported quarterly losses of $(0.34) per share which missed the analyst consensus estimate of $(0.14) by 142.86 percent. This is a 82.91 percent increase over losses of $(1.99) per

    DWTX